6-K
BROOKFIELD Corp /ON/ (BN)
UNITEDSTATESSECURITIES AND EXCHANGE COMMISSION****Washington, DC 20549
Form 6-K
Report of Foreign Private IssuerPursuant to Rule 13a-16 or 15d-16 ofthe Securities Exchange Act of 1934
| For the month of: June 2024 |
|---|
| Commission File Number: 001-15160 |
BrookfieldCorporation(Name of Registrant)
BrookfieldPlaceSuite 100181 Bay Street, P.O. Box 762Toronto, Ontario, Canada M5J 2T3(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
| Form 20-F<br> ¨ | Form 40-F<br> x |
|---|
Exhibit 99.1 of this Form 6-K shall be incorporated by reference as an exhibit to the Registration Statement of Brookfield Corporation and Brookfield Finance Inc. on Form F-10 (File Nos. 333-279601 and 333-279601-02).
EXHIBIT INDEX
| Exhibit | Description of Exhibit |
|---|---|
| 99.1 | Preliminary<br> Canadian Term Sheet, dated June 17, 2024 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BROOKFIELD CORPORATION | |||
|---|---|---|---|
| Date: June 17,<br> 2024 | By: | /s/<br> Swati Mandava | |
| Name: | Swati<br> Mandava | ||
| Title: | Managing Director,<br> Legal & Regulatory |
Exhibit 99.1
A final base shelf prospectus containingimportant information relating to the securities described in this document has been filed with the securities regulatory authoritiesin each of the provinces of Canada.
The final base shelf prospectus, any applicableshelf prospectus supplement and any amendment to the documents are accessible through SEDAR+. Copies of the documents may be obtainedfrom Merrill Lynch Canada Inc. by calling 416-369-7400 or by emailing dg.can_dcm@bankofamerica.com.
This document does not provide full disclosure of all materialfacts relating to the securities offered. Investors should read the final base shelf prospectus, any applicable shelf prospectus supplementand any amendment to the documents for disclosure of those facts, especially risk factors relating to the securities offered, beforemaking an investment decision.
BROOKFIELD FINANCE INC.
US$[●] [●]% NOTES DUE 2035
US$[100,000,000] 5.968% NOTES DUE 2054
PRELIMINARY TERM SHEET
June 17, 2024
| Issuer: | Brookfield Finance Inc. | |
|---|---|---|
| Guarantor: | Brookfield Corporation | |
| Guarantee: | The Notes (as defined below) will be fully and unconditionally<br> guaranteed as to payment of principal, premium (if any) and interest and certain other amounts by Brookfield Corporation. | |
| Guarantor’s Ticker: | BN | |
| Security: | [●]%<br> Senior Unsecured Notes due [●], 2035 (the “2035 Notes”)<br><br> <br><br><br> <br>5.968% Senior Unsecured Notes due March 4, 2054 (the “2054<br> Notes” and, together with the 2035 Notes, the “Notes”) | |
| Format: | SEC registered | |
| Size: | 2035 Notes: US$ Benchmark<br><br> <br>****<br><br> <br>2054 Notes: US$[100,000,000]<br><br> <br><br><br> <br>The 2054 Notes will be in addition to and form part of the same<br> series of notes as the US$750,000,000 aggregate principal amount of Brookfield Finance Inc.’s 5.968% notes due 2054, which<br> were originally issued on March 4, 2024 (the “Original 2054 Notes”). After giving effect to this offering, there<br> will be a total of US$[●] aggregate principal amount of notes of this series issued and outstanding.<br><br> <br><br><br> <br>One or more of the underwriters may sell to affiliates of Brookfield<br> Reinsurance Ltd. US$[●] aggregate principal amount (if any) of the 2035 Notes and US$[●] aggregate principal<br> amount (if any) of the 2054 Notes at the public offering price (for which no underwriting discount or commissions will be paid). | |
| Trade Date: | June 17, 2024 | |
| --- | --- | |
| Expected Settlement Date: | June 21, 2024 (T+3) | |
| Maturity Date: | 2035 Notes: [●], 2035<br><br> <br><br><br> <br>2054 Notes: March 4, 2054 | |
| Coupon: | 2035 Notes: [●]%<br><br> <br><br><br> <br>2054 Notes: 5.968% (interest on the 2054 Notes will accrue from<br> March 4, 2024) | |
| Interest Payment Dates: | 2035 Notes: [●] and [●], commencing [●], 20**[●]<br><br> <br><br><br> <br>2054 Notes: March 4 and September 4, commencing September 4,<br> 2024 | |
| Price to Public: | 2035 Notes: [●]%<br><br> <br><br><br> <br>2054 Notes: [●]% of principal amount plus accrued<br> interest of US$[●]** from March 4, 2024 | |
| Benchmark Treasury: | [The Spread to Benchmark Treasury, and any disclosure<br> relating to the Spread to Benchmark Treasury, has been removed in accordance with subsection 9A.3(4) of National Instrument<br> 44-102 – Shelf Distributions (“NI 44-102”).] | |
| Benchmark Treasury Price & Yield: | [The Spread to Benchmark Treasury, and any disclosure<br> relating to the Spread to Benchmark Treasury, has been removed in accordance with subsection 9A.3(4) of NI 44-102.] | |
| Spread to Benchmark Treasury: | [The Spread to Benchmark Treasury, and any disclosure<br> relating to the Spread to Benchmark Treasury, has been removed in accordance with subsection 9A.3(4) of NI 44-102.] | |
| Yield: | 2035 Notes: [●]%<br><br> <br><br><br> <br>2054 Notes: [●]% |
2
| Denominations: | Initial denominations of US$2,000 and subsequent<br> multiples of US$1,000 |
|---|---|
| Covenants: | Change of control (put @ 101%)<br><br> <br>Negative pledge<br><br> <br>Consolidation, merger, amalgamation and sale of substantial assets |
| Redemption Provisions: | |
| Make-Whole Call: | 2035 Notes: Prior to [●], 2034 (three months prior to maturity),<br> treasury rate plus [●] basis points<br><br> <br><br><br> <br>2054 Notes: Prior to September 4, 2053 (six months prior<br> to maturity), treasury rate plus 25 basis points |
| Par Call: | 2035 Notes: At any time on or after [●], 2034 (three months<br> prior to maturity), at 100% of the principal amount of the Notes to be redeemed<br><br> <br><br><br> <br>2054 Notes: At any time on or after September 4, 2053 (six<br> months prior to maturity), at 100% of the principal amount of the Notes to be redeemed |
| Use of Proceeds: | The net proceeds from the sale of the Notes will<br> be used for general corporate purposes |
| CUSIP/ISIN: | 2035 Notes: 11271L AM4 / US11271LAM46<br><br> <br><br><br> <br>2054 Notes: 11271L AL6 / US11271LAL62 |
| Joint Book-Running Managers^1^: | Deutsche Bank Securities Inc.<br><br> <br>BofA Securities, Inc. |
| Co-Managers: | [●] |
Capitalized terms used and not defined herein have the meanings assigned in the Issuer and the Guarantor’s Prospectus Supplement, dated June 17, 2024 to the Short Form Base Shelf Prospectus dated May 31, 2024.
^1^ This offering will be made in Canada by Merrill Lynch Canada Inc., a broker-dealer affiliate of BofA Securities, Inc.
3
Under Rule 15c6-1 under the ExchangeAct, trades in the secondary market generally are required to settle in one business day unless the parties to any such trade expresslyagree otherwise. Accordingly, purchasers who wish to trade the Notes prior to the delivery of the Notes hereunder may be required, byvirtue of the fact that the Notes initially will settle in T+3, to specify an alternative settlement cycle at the time of any such tradeto prevent a failed settlement. Purchasers of the Notes who wish to trade the Notes prior to their date of delivery hereunder shouldconsult their own advisors.
The 2035 Notes will be issued as a separate series of debt securitiesunder an eleventh supplemental indenture to be dated as of the date of the issuance of the 2035 Notes (the “Eleventh SupplementalIndenture”) to the base indenture dated as of June 2, 2016 (the “Base Indenture”) (together with the EleventhSupplemental Indenture, the “2035 Indenture”), between Brookfield Finance Inc., Brookfield Corporation, as guarantor, andComputershare Trust Company of Canada, as trustee. The 2054 Notes will be issued on the same terms and conditions as the Original 2054Notes, except for the issue date and the issue price, under the Base Indenture and the tenth supplemental indenture, dated as of March 4,2024 (the “Tenth Supplemental Indenture”), as supplemented by a supplemental indenture thereto (the “Supplemented TenthSupplemental Indenture” and together with the Base Indenture, the “2054 Indenture”). The 2035 Indenture and the 2054Indenture are together referred to as the “Indenture”. The foregoing is a summary of certain of the material attributes andcharacteristics of the Notes, which does not purport to be complete and is qualified in its entirety by reference to the Indenture.
No PRIIPs or UK PRIIPs key information document(KID) has been prepared as European Economic Area or UK retail investors are not targeted.
4